Teva settles with Louisiana for $18M over opioid claims; Video game treatment churns out PhII results
Teva Pharmaceuticals is paying the state of Louisiana $15 million in cash over the next 18 years, in exchange for being released from lawsuits over the state’s opioid claims.
As part of the agreement, Teva will also donate $3 million in opioid addiction recovery drugs — contingent upon being released from all Louisiana lawsuits by Nov. 2.
As the US-based subsidiary for Israel’s Teva Pharmaceutical Industries, Teva has been facing legal proceedings in a number of US states, including New York and California, amid claims that the company engaged in misleading marketing of opioids and downplayed the risks of opioid addiction.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.